189 related articles for article (PubMed ID: 10577937)
1. Complete inactivation of the TSC2 gene leads to formation of hamartomas.
Au KS; Hebert AA; Roach ES; Northrup H
Am J Hum Genet; 1999 Dec; 65(6):1790-5. PubMed ID: 10577937
[No Abstract] [Full Text] [Related]
2. A tuberous sclerosis patient with a large TSC2 and PKD1 gene deletion shows extrarenal signs of autosomal dominant polycystic kidney disease.
Longa L; Brusco A; Carbonara C; Polidoro S; Scolari F; Valzorio B; Riegler P; Tardanico R; Migone N
Contrib Nephrol; 1997; 122():91-5. PubMed ID: 9399046
[No Abstract] [Full Text] [Related]
3. Renal disease in adults with TSC2/PKD1 contiguous gene syndrome.
Martignoni G; Bonetti F; Pea M; Tardanico R; Brunelli M; Eble JN
Am J Surg Pathol; 2002 Feb; 26(2):198-205. PubMed ID: 11812941
[TBL] [Abstract][Full Text] [Related]
4. Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions.
Niida Y; Stemmer-Rachamimov AO; Logrip M; Tapon D; Perez R; Kwiatkowski DJ; Sims K; MacCollin M; Louis DN; Ramesh V
Am J Hum Genet; 2001 Sep; 69(3):493-503. PubMed ID: 11468687
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis and association with tuberous sclerosis genes TSC1 and TSC2.
Maruyama H; Ohbayashi C; Hino O; Tsutsumi M; Konishi Y
Pathol Int; 2001 Aug; 51(8):585-94. PubMed ID: 11564212
[TBL] [Abstract][Full Text] [Related]
6. Apparent preferential loss of heterozygosity at TSC2 over TSC1 chromosomal region in tuberous sclerosis hamartomas.
Carbonara C; Longa L; Grosso E; Mazzucco G; Borrone C; Garrè ML; Brisigotti M; Filippi G; Scabar A; Giannotti A; Falzoni P; Monga G; Garini G; Gabrielli M; Riegler P; Danesino C; Ruggieri M; Magro G; Migone N
Genes Chromosomes Cancer; 1996 Jan; 15(1):18-25. PubMed ID: 8824721
[TBL] [Abstract][Full Text] [Related]
7. Tuberous sclerosis gene products in proliferation control.
Hengstschläger M; Rodman DM; Miloloza A; Hengstschläger-Ottnad E; Rosner M; Kubista M
Mutat Res; 2001 Jul; 488(3):233-9. PubMed ID: 11397651
[TBL] [Abstract][Full Text] [Related]
8. Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma.
El-Hashemite N; Zhang H; Henske EP; Kwiatkowski DJ
Lancet; 2003 Apr; 361(9366):1348-9. PubMed ID: 12711473
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas.
Henske EP; Neumann HP; Scheithauer BW; Herbst EW; Short MP; Kwiatkowski DJ
Genes Chromosomes Cancer; 1995 Aug; 13(4):295-8. PubMed ID: 7547639
[TBL] [Abstract][Full Text] [Related]
10. TSC1 and TSC2: genes that are mutated in the human genetic disorder tuberous sclerosis.
Sampson JR
Biochem Soc Trans; 2003 Jun; 31(Pt 3):592-6. PubMed ID: 12773162
[TBL] [Abstract][Full Text] [Related]
11. Tuberous sclerosis complex: multisystem hamartomas.
Naderi N; Timofte I; McCurdy MT; Reed RM
BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25618887
[No Abstract] [Full Text] [Related]
12. [Tests for loss of heterozygosity in tuberous sclerosis].
Jóźwiak S; Dabora S; Kasprzyk-Obara J; Domańska-Pakieła D; Grajkowska W
Przegl Lek; 2001; 58 Suppl 1():12-5. PubMed ID: 11355103
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs.
Dabora SL; Jozwiak S; Franz DN; Roberts PS; Nieto A; Chung J; Choy YS; Reeve MP; Thiele E; Egelhoff JC; Kasprzyk-Obara J; Domanska-Pakiela D; Kwiatkowski DJ
Am J Hum Genet; 2001 Jan; 68(1):64-80. PubMed ID: 11112665
[TBL] [Abstract][Full Text] [Related]
14. Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development.
Giannikou K; Malinowska IA; Pugh TJ; Yan R; Tseng YY; Oh C; Kim J; Tyburczy ME; Chekaluk Y; Liu Y; Alesi N; Finlay GA; Wu CL; Signoretti S; Meyerson M; Getz G; Boehm JS; Henske EP; Kwiatkowski DJ
PLoS Genet; 2016 Aug; 12(8):e1006242. PubMed ID: 27494029
[TBL] [Abstract][Full Text] [Related]
15. The TSC2/PKD1 contiguous gene syndrome.
Harris PC
Contrib Nephrol; 1997; 122():76-82. PubMed ID: 9399043
[No Abstract] [Full Text] [Related]
16. Carcinomalike monotypic epithelioid angiomyolipoma in patients without evidence of tuberous sclerosis: a clinicopathologic and genetic study.
Martignoni G; Pea M; Bonetti F; Zamboni G; Carbonara C; Longa L; Zancanaro C; Maran M; Brisigotti M; Mariuzzi GM
Am J Surg Pathol; 1998 Jun; 22(6):663-72. PubMed ID: 9630173
[TBL] [Abstract][Full Text] [Related]
17. Germ-line mosaicism in tuberous sclerosis: how common?
Rose VM; Au KS; Pollom G; Roach ES; Prashner HR; Northrup H
Am J Hum Genet; 1999 Apr; 64(4):986-92. PubMed ID: 10090883
[TBL] [Abstract][Full Text] [Related]
18. TSC1 and TSC2 gene mutations in human kidney tumors.
Kajino K; Hino O
Contrib Nephrol; 1999; 128():45-50. PubMed ID: 10597376
[No Abstract] [Full Text] [Related]
19. Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene.
Sampson JR; Maheshwar MM; Aspinwall R; Thompson P; Cheadle JP; Ravine D; Roy S; Haan E; Bernstein J; Harris PC
Am J Hum Genet; 1997 Oct; 61(4):843-51. PubMed ID: 9382094
[TBL] [Abstract][Full Text] [Related]
20. Analysis of a Mouse Skin Model of Tuberous Sclerosis Complex.
Guo Y; Dreier JR; Cao J; Du H; Granter SR; Kwiatkowski DJ
PLoS One; 2016; 11(12):e0167384. PubMed ID: 27907099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
